Clinical Trials on Chronic HCV Infection in China

Total 6592 results

Jun Zhang
National Natural Science Foundation of China; Merck Sharp & Dohme LLC

Completed

A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China

Congenital Cytomegalovirus Infection | Cytomegalovirus Infection Reactivation

China
Foundation for Liver Research

Completed

Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB (PEGON)

Chronic Hepatitis B

Netherlands, China
Chinese University of Hong Kong
GlaxoSmithKline; Hoffmann-La Roche

Completed

Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients

Chronic Hepatitis B

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Trial of TQA3038 Injection in Healthy Adult Subjects

Chronic Hepatitis b

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Active, not recruiting

A Study of LP-128 Capsules in Healthy Subjects

Chronic Hepatitis b

China
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

Safety and Efficacy of T8 on Treating Chronic Abnormal Immune Activation in HIV/AIDS Patients

Chronic Abnormal Immune Activation in HIV/AIDS

China
Third Affiliated Hospital, Sun Yat-Sen University

Unknown

TDF Combined With LDT for the Treatment of HBeAg-positive Hepatitis B Patients With Poor Response to TDF for 12 Months

Chronic Hepatitis B

China
Beijing Ditan Hospital

Unknown

The Study of Short-range Antiviral Treatment During Pregnancy to Block Mother-to-child Transmission of Hepatitis B Virus and Withdrawal Time

Chronic Hepatitis B

China
Sunshine Lake Pharma Co., Ltd.

Completed

The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules

Chronic Hepatitis B

China
Sunshine Lake Pharma Co., Ltd.

Completed

The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects

Chronic Hepatitis c

China
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Completed

The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers

Chronic Hepatitis B

China
Zhejiang University

Unknown

Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients

Chronic Hepatitis B | Hepatic Steatosis

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B

Chronic Hepatitis B

China
Chinese University of Hong Kong
GlaxoSmithKline

Completed

Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)

Chronic Hepatitis B

China
Qilu Pharmaceutical Co., Ltd.

Unknown

An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b

Chronic Hepatitis b

China
Shandong University

Unknown

The Situation of Re-infection of Helicobacter Pylori After Successful Eradication

Helicobacter Pylori

China
Sunshine Lake Pharma Co., Ltd.

Completed

The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects

Chronic Hepatitis C

China
Sunshine Lake Pharma Co., Ltd.

Completed

The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects

Chronic Hepatitis c

China
Ascletis Pharmaceuticals Co., Ltd.

Completed

A Study to Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China

Chronic Hepatitis c

China
Bristol-Myers Squibb

Completed

Study to Assess Clinical Outcomes in Chronic Hepatitis C Patients Previously Treated With Daclatasvir-Based Regimens

Hepatitis C

China
Xijing Hospital of Digestive Diseases

Recruiting

Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication

Helicobacter Pylori Infection | Chronic Gastritis

China
Peking University First Hospital
Beijing Municipal Science & Technology Commission

Completed

Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B

Chronic Hepatitis B

China
Chinese University of Hong Kong
Hoffmann-La Roche

Completed

Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment

Chronic Hepatitis B

China
Lu KZ

Completed

The Effect of General Anesthesia Immunosuppressive on Hepatitis B Virus Replication (HBV)

HBV Infection

China
Third Affiliated Hospital, Sun Yat-Sen University

Completed

Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6

Chronic Hepatitis C

China
Beijing 302 Hospital

Terminated

Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B Patients

Hepatitis B, Chronic

China
Shanghai Nanhui Nanhua Hospital

Active, not recruiting

The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCC

Hepatitis B

China
Peking University First Hospital

Completed

Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection

Hepatitis B

China
The Fifth People's Hospital of Suzhou

Unknown

Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)

Liver Cirrhosis | Chronic Hepatitis B

China
Lizora LLC
Sheng'ai Traditional Chinese Medicine Hospital

Completed

Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning

COVID-19 | Influenza | Post-COVID-19 Syndrome

China
Xingfei Pan

Enrolling by invitation

Efficacy and Adverse Effects of Nucleoside Analogues (TDF/LDT) in Preventing Mother-to-child Transmission of HBV

Chronic Hepatitis b | Women

China
Huashan Hospital

Active, not recruiting

Efficacy and Safety of TAF for 48 Weeks in HBeAg Positive CHB Patients

Chronic Hepatitis B

China
Bristol-Myers Squibb

Terminated

Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)

Chronic Hepatitis C

China
The University of Hong Kong
Research Grant Council

Recruiting

Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B

Cirrhosis | NAFLD | Chronic Hepatitis b | Fibrosis, Liver | Empagliflozin | SGLT2 Inhibitors

Hong Kong
Qilu Hospital of Shandong University

Recruiting

A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance

Chronic Hepatitis B

China
Third Affiliated Hospital, Sun Yat-Sen University

Recruiting

The Efficacy and Safety of TAF vs Other NAs in Patients With LVL

Chronic Hepatitis b | Cirrhosis Due to Hepatitis B

China
First Affiliated Hospital Xi'an Jiaotong University
Yan'an University Affiliated Hospital

Unknown

Evaluation of Antiviral Indications on Chronic HBV Infection With Different Transaminase Levels

Chronic Hepatitis b | ALT

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Recruiting

Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD

Non-alcoholic Fatty Liver Disease | Chronic Hepatitis b

China
Third Affiliated Hospital, Sun Yat-Sen University

Recruiting

Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF

Acute-On-Chronic Liver Failure | Hepatitis B, Chronic

China
Henan Provincial People's Hospital

Recruiting

Study on Clinical Program Optimization of Inactive Hepatitis B Surface Antigen (HBsAg) Carriers (IHCs)

Chronic Hepatitis B

China
Henan Provincial People's Hospital
Xiamen Amoytop Biotech Co., Ltd.

Completed

Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy

Chronic Hepatitis B

China
Xi'an Traditional Medicine Hospital

Unknown

The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis B

Hepatitis B， Chronic

China
Beijing Ditan Hospital

Unknown

Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment

Chronic Hepatitis B

China
The Second Affiliated Hospital of Chongqing Medical...

Unknown

A Study of Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/ml (New Switch)

Chronic Hepatitis B

China
First People's Hospital of Hangzhou

Recruiting

Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women

Chronic Hepatitis b | Tenofovir Alafenamide Fumarate

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of TQA3810 Tablets

Chronic Hepatitis B

China
Shanghai HEP Pharmaceutical Co., Ltd.

Completed

Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers

Hepatitis B， Chronic

China
Shanghai HEP Pharmaceutical Co., Ltd.

Completed

Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers

Hepatitis B， Chronic

China
Fuzhou General Hospital

Recruiting

Peginterferon Alpha-2b Therapy in Chronic Hepatitis Patients With Normal ALT Level and Low Viremia

Chronic Hepatitis B Patients With a Normal ALT Level and Low Viremia

China
Gilead Sciences

Completed

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)

HBV | Chronic HBV Infections

China

3

Subscribe